Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-30T05:58:31.058Z Has data issue: false hasContentIssue false

31 - Gynaecological cancers in childhood

from Part III - Management of specific disorders

Published online by Cambridge University Press:  04 May 2010

Tito Lopes
Affiliation:
Queen Elizabeth Hospital, Gateshead, UK
Adam H. Balen
Affiliation:
Leeds Teaching Hospitals, University Trust
Sarah M. Creighton
Affiliation:
University College London Hospitals
Melanie C. Davies
Affiliation:
University College London
Jane MacDougall
Affiliation:
Addenbrooke's Hospital, Cambridge
Richard Stanhope
Affiliation:
Great Ormond Street Hospital
Get access

Summary

Introduction

Childhood cancers are rare, with approximately 1300 new cases a year in the UK (up to age 15) while in the USA the incidence is estimated at 15.1/105 (less than age 20), accounting for approximately 2% of all cancers.

Because of their rarity, childhood cancers should be managed in tertiary referral centres, using a multidisciplinary approach with participation in national and international trials. Only in this way can management of these children improve along with advancing our knowledge and study of childhood cancers.

Various national and international organizations have been established in the last 40 years to advance the care of children with cancer. In the USA, the Children's Cancer Group (CCG) founded in 1955, the Pediatric Oncology Group (POG) created in 1980, the National Wilm's Tumour Study Group and the Intergroup Rhabdomyosarcoma Study Group (IRSG) have recently merged to form the Children's Oncology Group. In Europe the Société International d'Oncologie Pédiatrique (SIOP) was created in 1969.

In the UK, the Children's Cancer Study Group (UKCCSG) was created in 1977 and currently has 22 paediatric treatment centres within the UK. The proportion of children treated at UKCCSG centres has increased over recent years, as a result of tertiary referral, to approximately 80% of all children with cancer. A high proportion of these children are entered into clinical trials and as a result there has been an improvement in their survival, compared with those treated elsewhere.

Type
Chapter
Information
Paediatric and Adolescent Gynaecology
A Multidisciplinary Approach
, pp. 389 - 396
Publisher: Cambridge University Press
Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arndt, C A, Donaldson, S S, Anderson, J R et al. (2001). What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?Cancer 91, 2454–24683.0.CO;2-C>CrossRefGoogle ScholarPubMed
Baranzelli, M C, Kramar, A, Bouffet, E et al. (1999). Prognostic factors in children with localized malignant nonseminomatous germ cell tumors. J Clin Oncol 17, 1212CrossRefGoogle ScholarPubMed
Baranzelli, M C, Bouffet, E, Quintana, E, Portas, M, Thyss, A, Patte, C (2000). Non-seminomatous ovarian germ cell tumours in children. Eur J Cancer 36, 376–383CrossRefGoogle ScholarPubMed
Barber, H R, Graber, E A (1973). Gynecological tumors in childhood and adolescence. Obstet Gynecol Surv 28 (Suppl.), 357–381CrossRefGoogle ScholarPubMed
Brodeur, G M, Howarth, C B, Pratt, C B, Caces, J, Hustu, H O (1981). Malignant germ cell tumors in 57 children and adolescents. Cancer 48, 1890–18983.0.CO;2-D>CrossRefGoogle ScholarPubMed
Brown, M F, Hebra, A, McGeehin, K, Ross, A J, III (1993). Ovarian masses in children: a review of 91 cases of malignant and benign masses. J Pediatr Surg 28, 930–931CrossRefGoogle ScholarPubMed
Calaminus, G, Wessalowski, R, Harms, D, Gobel, U (1997). Juvenile granulosa cell tumors of the ovary in children and adolescents: results from 33 patients registered in a prospective cooperative study. Gynecol Oncol 65, 447–452CrossRefGoogle Scholar
Cass, D L, Hawkins, E, Brandt, M L et al. (2001). Surgery for ovarian masses in infants, children, and adolescents: 102 consecutive patients treated in a 15-year period. J Pediatr Surg 36, 693–699CrossRefGoogle Scholar
Corpron, C A, Andrassy, R J, Hays, D M et al. (1995). Conservative management of uterine pediatric rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III and IV pilot. J Pediatr Surg 30, 942–944CrossRefGoogle ScholarPubMed
Critchley, H O, Wallace, W H, Shalet, S M, Mamtora H, Higginson J, Anderson D C (1992). Abdominal irradiation in childhood; the potential for pregnancy. Br J Obstet Gynaecol 99, 392–394CrossRefGoogle ScholarPubMed
Cronje, H S, Niemand, I, Bam, R H, Woodruff, J D (1998). Abdominal irradiation in childhood; the potential for pregnancy. Obstet Gynecol Surv 53, 240–247CrossRefGoogle Scholar
Cushing, B, Giller, R, Ablin, A et al. (1999). Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group. Am J Obstet Gynecol 181, 353–358CrossRefGoogle ScholarPubMed
Dewhurst, C J (1977). Tumors of the genital tract in childhood and adolescence. Clin Obstet Gynecol 20, 595–606CrossRefGoogle ScholarPubMed
Gallion, H, Nagell, J R Jr, Powell, D F, Donaldson, E S, Hanson, M (1979). Therapy of endodermal sinus tumor of the ovary. Am J Obstet Gynecol 135, 447–451CrossRefGoogle ScholarPubMed
Herbst, A L, Scully, R E (1970). Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer 25, 745–7573.0.CO;2-2>CrossRefGoogle Scholar
Herbst, A L, Ulfelder, H, Poskanzer, D C (1971). Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284, 878–881CrossRefGoogle ScholarPubMed
Vecchia, C, Morris, H B, Draper, G J (1983). Malignant ovarian tumours in childhood in Britain, 1962–78. Br J Cancer 48, 363–374CrossRefGoogle ScholarPubMed
Vecchia, C, Draper, G J, Franceschi, S (1984). Childhood nonovarian female genital tract cancers in Britain, 1962–1978. Descriptive epidemiology and long-term survival. Cancer 54, 188–1923.0.CO;2-5>CrossRefGoogle ScholarPubMed
Lawrence, W Jr, Anderson, J R, Gehan, E A, Maurer, H (1997). Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group, Children's Cancer Study Group and Pediatric Oncology Group. Cancer 80, 1165–11703.0.CO;2-5>CrossRefGoogle Scholar
Mann, J R, Raafat, F, Robinson, K et al. (2000). The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 18, 3809–3818CrossRefGoogle ScholarPubMed
Martelli, H, Oberlin, O, Rey, A et al. (1999). Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: a report from the Study Committee of the International Society of Pediatric Oncology. J Clin Oncol 17, 2117–2122CrossRefGoogle Scholar
Qualman, S J, Coffin, C M, Newton, W A et al. (1998). Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 1, 550–561CrossRefGoogle ScholarPubMed
Ries L A G, Eisner M P, Kosary C L et al. (2001). SEER cancer statistics review 1973–1998. National Cancer Institute, Bethesda, MD http://seer.cancer.gov/
Rodary, C, Flamant, F, Donaldson, S S (1989). An attempt to use a common staging system in rhabdomyosarcoma: a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). Med Pediatr Oncol 17, 210–215CrossRefGoogle Scholar
Waggoner, S E, Mittendorf, R, Biney, N, Anderson, D, Herbst, A L (1994). Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol 55, 238–244CrossRefGoogle ScholarPubMed
Wallace, W H, Blacklay, A, Eiser, C et al. (2001). Developing strategies for long term follow up of survivors of childhood cancer. BMJ 323, 271–274CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×